Podcasts
MGI Podcasts
Discover the world of genomics through our engaging podcast series, where we bring you expert insights, in-depth discussions, and the latest advancements in science and technology.
Each episode features conversations with leading researchers, innovators, and industry pioneers, providing a deeper understanding of the cutting-edge developments shaping the future of genomics, precision medicine, and beyond.
Whether you’re exploring new technologies, learning about breakthrough applications, or gaining valuable perspectives on the future of scientific research, our podcasts offer a wealth of knowledge to keep you informed and inspired.
MGI Podcasts
28:29
32:55
43:49
36:07
43:48
36:34
43:48
36:02
40:53
37:08
25:38
May, observed as Melanoma Awareness Month, underscores the growing relevance of genomic technologies in advancing melanoma research, tumor immunology, and precision oncology. It also provides context for highlighting how spatial and multiomics approaches are improving resolution in cancer biology.
Researchers at the University Hospital Magdeburg and the University Hospital Schleswig-Holstein (in Lübeck) are conducting a melanoma profiling study using clinically annotated samples from an institutional biobank. The project is supported through collaboration with Dr. Jia Hui Khoo, Senior Product Manager at MGI Tech, who contributes expertise in spatial biology and enabling technologies. The study integrates DNA, cellular, spatial, and proteomic data through MGI’s DCSP framework to support translational cancer research.
As we approach World Cancer Day on February 4th, this episode of DNA Today takes a global look at how cancer diagnostics are evolving, not just in research settings, but in real-world clinical laboratories where innovation must meet reliability, scalability, and patient impact.
In this conversation, we bring together three experts from around the world working at the intersection of oncology diagnostics, sequencing technology, and clinical implementation.
Joining us from Portugal is Dr. Jorge Lima of IPATIMUP, one of Europe’s leading oncology centers known for its research-driven diagnostic mission. From Italy, Bernard Okere joins us as a Field Application Scientist at MGI Tech, a company providing a full spectrum of sequencing platforms and automation solutions for life science and clinical laboratories worldwide. And from China, we’re joined by Nancy Yang, International Senior Business Development Manager at Gene+, a genetic testing and precision oncology company behind one of the largest oncology gene panels currently in clinical use.
Together, we explore how IPATIMUP has implemented large-scale DNA and RNA sequencing, including Gene+’s 1,021-gene DNA panel and RNA sequencing, to expand diagnostic confidence while maintaining rigorous clinical standards. This episode dives into validation, automation, workflow design, and cross-company partnerships, offering a behind-the-scenes look at how modern oncology labs grow without compromising quality.
According to American Cancer Society, Cancer causes about 1 in every 6 deaths globally, more than AIDS, tuberculosis, and malaria combined. Today, it is the first or second leading cause of death in most countries around the world. Technological advances in genomics have enabled the identification and improved understanding of causal factors and shed light on precision oncology.
In this episode, Dr. Marie-Laure Yaspo from ALACRIS Theranostics is working towards closing the care gap with evidence-based strategies in cancer control along the care continuum, from prevention to treatment, with help from MGI’s cutting-edge life science technologies.
Dive into the world of rare diseases with Bruno Reversade on our latest podcast episode! On RareDiseaseDay, he sheds light on Mendelian Disorders, where a single gene defect can hold the key to understanding and treating these conditions.
Bruno highlights the game-changing impact of sequencing technology, sharing, “We’ve essentially been able to, within a matter of days or hours, sequence our entire exome – the coding part of our genome. This has introduced a paradigm shift in the efficacy of diagnostics, revolutionizing the speed and depth of our research.”
Join us as we explore the frontier of genomics, unravelling genetic complexities and embracing hope for breakthroughs in rare disease research. Listen now and be part of the conversation!
During World Immunization Week, we had a chat with professor Medhat Askar, Associate Vice President for Clinical Affairs and Professor of Immunology at Qatar University’s College of Medicine. We talked about his work at transplant immunology, discussing how the evolution of NGS technologies have helped overcome challenges in histocompatibility and learning about how genetic identity testing can help achieve successful transplants.
Doping scandals have have frequently occurred in the history of the Olympic Games, highlighting the need for stronger anti-doping measures. Today, we’re honored to speak with Prof Yannis Pitsiladis from Hong Kong Baptist University, a pioneer in anti-doping research and a key member of the International Olympic Committee Medical and Scientific Commission.
Prof Pitsiladis is at the forefront of using gene sequencing technology to enhance anti-doping efforts, bringing cutting-edge science to the fight for fair play in sports.
As we celebrate World Cancer Day, we’re spotlighting the transformative impact of genomics in precision medicine for oncology. The theme of World Cancer Day 2025 is “United by Uniquel”, today in the latest episode of the MGI podcast, we invite industry experts shared their insights on the evolving landscape of genomic medicine, and multiple collaborative entities unite in their mission to conquer cancers—
- Dr Cheng Boon – Oncologist and OncoDNA UK Medical Director, shares frontline clinical insights
- Dr Gareth Gerrard – Clinical Scientist and Scientific Lead for Cancer at the South East Genomics Laboratory Hub, London, discusses the challenges and opportunities in implementation.
- Filips Oleskovs – Business Development at MGI Tech, representing the technology provider’s perspective, highlighted the innovations driving broader accessibility.
MGI Podcast EP06: Reshaping Diagnosis and Care for Rare and Undiagnosed Diseases in Türkiye
Türkiye, located at the junction of Europe and Asia, is renowned for its genetically diverse population and has nearly 41 gene centres spread across 81 cities(and care is accessible within 50 kilometres). It is rapidly rising to become an important hub in medical genomics.
Dr. Serdar Ceylaner, a Turkish geneticist and the founder of Intergen Genetics and Rare Disease Diagnosis Centre, said that Türkiye is facing a complex genetic challenge with a 25% high rate of consanguinity, and it amplifies recessive disorders and complex, multi-disease presentations. T7 is fast and low-cost, making it highly suitable for sequencing needs in neonatology and intensive care units, allowing critically ill children to receive reports within 3 to 6 days.
MGI Podcast EP07：Changing the course of breast cancer prevention and care in Italy
Breast cancer remains one of the most common cancers worldwide, and in Italy, it is the most frequent malignancy among women with approximately 55,000 new diagnoses annually. While lifestyle and environmental factors often play significant roles in cancer development, a critical portion—at least 10% of breast cancer cases in the country—is hereditary in origin, according to Dr. Beatrice Salvatori, Scientist and Project Manager at Negedia.
We’re excited to have joined the podcast with Gustavo Riedel from Dasa and had a great conversation with Daniel Coriolano!
Together, we shared insights into our exciting collaboration with Dasa, and how MGI and Dasa will work hand-in-hand to bring advanced gene sequencing to Brazil’s clinical market. This partnership is set to enhance health diagnostics and benefit patients across the country, and to enable Brazilian’s access to genomic testing. So that more Brazilians can benefit from the latest advancements in precision medicine.
Sales Director from MGI Brazil was interviewed on the latest episode of MEDCAST – Podcast de Medicina!
Tune in to hear insights into the intersection of medicine and business, and how MGI is driving innovation in Brazilian healthcare.
